Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
MFS Blended Research Value Equity B BRUEX
- NAV / 1-Day Return 15.94 / −0.38 %
- Total Assets 289.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.490%
- Distribution Fee Level Low
- Share Class Type —
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Closed
- TTM Yield —
- Turnover 51%
USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:10 PM GMT+0
Morningstar’s Analysis BRUEX
Will BRUEX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 21.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
JPMorgan Chase & Co | 3.58 | 10.7 Mil | Financial Services |
Johnson & Johnson | 2.86 | 8.6 Mil | Healthcare |
Wells Fargo & Co | 2.30 | 6.9 Mil | Financial Services |
Berkshire Hathaway Inc Class B | 2.01 | 6.0 Mil | Financial Services |
Pfizer Inc | 1.95 | 5.8 Mil | Healthcare |
The Cigna Group | 1.90 | 5.7 Mil | Healthcare |
Phillips 66 | 1.75 | 5.2 Mil | Energy |
Salesforce Inc | 1.71 | 5.1 Mil | Technology |
ConocoPhillips | 1.69 | 5.1 Mil | Energy |
Eaton Corp PLC | 1.63 | 4.9 Mil | Industrials |